Correlation Between Sonnet Biotherapeutics and DiaMedica Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and DiaMedica Therapeutics, you can compare the effects of market volatilities on Sonnet Biotherapeutics and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and DiaMedica Therapeutics.

Diversification Opportunities for Sonnet Biotherapeutics and DiaMedica Therapeutics

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Sonnet and DiaMedica is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and DiaMedica Therapeutics go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and DiaMedica Therapeutics

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the DiaMedica Therapeutics. In addition to that, Sonnet Biotherapeutics is 2.28 times more volatile than DiaMedica Therapeutics. It trades about -0.59 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about -0.08 per unit of volatility. If you would invest  438.00  in DiaMedica Therapeutics on August 24, 2024 and sell it today you would lose (20.00) from holding DiaMedica Therapeutics or give up 4.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sonnet Biotherapeutics Holding  vs.  DiaMedica Therapeutics

 Performance 
       Timeline  
Sonnet Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
DiaMedica Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, DiaMedica Therapeutics is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Sonnet Biotherapeutics and DiaMedica Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonnet Biotherapeutics and DiaMedica Therapeutics

The main advantage of trading using opposite Sonnet Biotherapeutics and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.
The idea behind Sonnet Biotherapeutics Holdings and DiaMedica Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume